Dr. Lee Schwamm

@Braindoc_MGH

SVP/Chief Digital Health Officer @YNHHealth + Assoc Dean, Digital Strategy & TX @YaleMed + MD @StrokeAHA_ASA = Digital Transformation to Democratize Healthcare

New Haven, CT yalemedicine.org Joined February 2009

227 Following 2K Followers 838 Posts

Latest posts 5

Dr. Lee Schwamm @Braindoc_MGH May 8

Great time speaking with my good friends and colleagues @hmkyale and @thehowie on their podcast Health Veritas about how we are vetting and implementing AI and digital transformation at Yale School of Medicine and the Yale New Haven Health System.
insights.som.yale.edu/podcasts/healt…

insights.som.yale.edu Lee Schwamm: Onboarding AI at the Hospital Howie and Harlan are joined by Lee Schwamm, the Yale School of Medicine’s associate dean for digital strategy & transformation and chief digital health officer of the Yale New Haven Health System, to...

Dr. Lee Schwamm @Braindoc_MGH Apr 29

Join us May 26 @ynhhealth Health AI Symposium. World-class national leaders in conversation about where the rubber meets the road in actual health AI implementation. Real world problems solved by real world innovators for real world patients. Register @
ynhh.org/health-ai-symp…

Dr. Lee Schwamm @Braindoc_MGH Mar 26

Excited to be at Yale @YaleMed Medical AI Symposium and hearing from Dean Nancy Brown and Susan Gregurick, Ph.D. From @NIH on the various programmatic elements to support translational medical AI.

Dr. Lee Schwamm @Braindoc_MGH Feb 11

From evidence to guidelines to practice is what AHA does best!
@AHAScience

AHA Science Verified account @AHAScience Feb 5

📢Hot topic at #ISC26: 2026 AIS Guideline

Key updates to this guideline include the incorporation of new evidence related to thrombolytic choice and eligibility, determination of eligibility for endovascular thrombectomy,

Mobile stroke units enable rapid identification and treatment of thrombolytic-eligible patients with acute ischemic stroke.

@BraydonDymm

View quoted post on X

Dr. Lee Schwamm @Braindoc_MGH Feb 6

Loberamisal trial in moderate AIS <48h, ~1000 pts in <1 yr from the amazing Tiantan Hospital group shows this PSD95 Inhibitor led to substantial 13% improvement at 90d without safety concerns! Wow!!! Validate in addl populations!

#ISC26 @AHAScience